3169 results for «338»

Filter By

3169 results

Procedural optimisation for enhanced acute and long-term outcomes

14 Feb 2026 – From PCR Tokyo Valves 2026

This session emphasizes procedural optimization in TAVI to enhance both acute and long-term outcomes. It highlights critical factors such as valve sizing, expansion, implantation depth, and commissural alignment. Practical techniques for pre- and post-dilatation alongside commissural alignment are demonstrated through real cath lab cases, underscoring their...

Procedural optimisation for enhanced acute and long-term outcomes

Patient selection for tricuspid TEER in 2026

14 Feb 2026 – From PCR Tokyo Valves 2026

This session focuses on optimizing patient selection for tricuspid transcatheter edge-to-edge repair (TEER) in 2026. It integrates anatomical, haemodynamic, and clinical criteria to identify ideal candidates, explores evolving treatment boundaries between TEER, transcatheter tricuspid valve replacement (TTVR), and medical management, and applies evidence from key trials...

Patient selection for tricuspid TEER in 2026

Mastering techniques from basic to complex - Tricuspid TEER fundamentals

13 Feb 2026 – From PCR Tokyo Valves 2026

Gain foundational knowledge in tricuspid TEER by understanding anatomical criteria for patient suitability, key procedural steps, and device techniques, enhanced by simulation-based procedural training.

Mastering techniques from basic to complex - Tricuspid TEER fundamentals

Getting ready for tricuspid TEER: key steps in building a successful programme

14 Feb 2026 – From PCR Tokyo Valves 2026

Prepare to establish a successful tricuspid TEER programme by understanding essential components such as systematic echocardiographic and clinical assessments for patient selection, procedural fundamentals, and programme development supported by clinical evidence.

Getting ready for tricuspid TEER: key steps in building a successful programme

Mastering techniques from basic to complex - Mitral regurgitation assessment and suitability for TEER

13 Feb 2026 – From PCR Tokyo Valves 2026

Delve into the assessment of mitral regurgitation and the criteria determining suitability for Transcatheter Edge-to-Edge Repair (TEER). This session reviews mitral valve anatomy and the latest clinical data supporting mitral TEER interventions.

Mastering techniques from basic to complex - Mitral regurgitation assessment and suitability for TEER

Mastering techniques from basic to complex - Advanced TAVI

13 Feb 2026 – From PCR Tokyo Valves 2026

Explore advanced TAVI topics including valve selection for small annuli, optimization strategies for bicuspid aortic valve interventions, and techniques ensuring safety and efficacy in valve-in-valve procedures.

Mastering techniques from basic to complex - Advanced TAVI

Coronary access and revascularisation in patients undergoing TAVI: from work-up to lifetime management

15 Feb 2026 – From PCR Tokyo Valves 2026

This session delves into the comprehensive management of ischemic heart disease in patients undergoing transcatheter aortic valve implantation (TAVI). It highlights the critical importance of maintaining coronary access post-TAVI and explores how various valve designs affect coronary accessibility, particularly in cases involving valve-in-valve (TAV-in-TAV) procedures, guiding...

Coronary access and revascularisation in patients undergoing TAVI: from work-up to lifetime management

TRIGISTRY: Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE

31 Aug 2024

Alex Sticchi provides his take on the TRIGISTRY study presented by Julien Dreyfus at the ESC Congress 2024 in London.

Simultaneous publication in European Heart Journal, ehae578

Alessandro Sticchi

Author

Alessandro Sticchi
Benefit of isolated surgical valve repair or replacement for functional TR and long-term outcomes

PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction

03 Apr 2022

Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.

Nicola Ryan

Author

Nicola Ryan
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial
Didn’t find what you were looking for?